BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 12601443)

  • 21. Organization and operation of P & T Committees in the state of Florida: a survey.
    Hatton RC; Doering PL
    Hosp Formul; 1990 Sep; 25(9):983-6, 988-9. PubMed ID: 10106259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. P & T Committee perspectives: maintaining a successful formulary system in a private community hospital.
    Benner EJ; Mykita L; Brown K
    Hosp Formul; 1990 Apr; 25(4):423-6, 428, 430. PubMed ID: 10104233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formularies: the role of pharmacy-and-therapeutics (P&T) committees.
    Summers KH; Szeinbach SL
    Clin Ther; 1993; 15(2):433-41; discussion 432. PubMed ID: 8519049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. P & T Committee problem-solving in a Canadian specialty hospital.
    Feld R
    Hosp Formul; 1986 Jul; 21(7):778-9, 783-4. PubMed ID: 10277344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Literature review on the structure and operation of Pharmacy and Therapeutics Committees.
    Durán-García E; Santos-Ramos B; Puigventos-Latorre F; Ortega A
    Int J Clin Pharm; 2011 Jun; 33(3):475-83. PubMed ID: 21416393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacoeconomic analysis in formulary decisions: an international perspective.
    Johnson JA; Bootman JL
    Am J Hosp Pharm; 1994 Oct; 51(20):2593-8. PubMed ID: 7847423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validating a hospital medicines formulary survey in the Western Pacific Region--a global hospital pharmacy initiative based on the Basel Statements.
    Penm J; Chaar B; Moles R
    Res Social Adm Pharm; 2012; 8(4):298-308. PubMed ID: 22169173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ASHP guidelines on formulary system management.
    Am J Hosp Pharm; 1992 Mar; 49(3):648-52. PubMed ID: 1598948
    [No Abstract]   [Full Text] [Related]  

  • 29. P & T Committee interview: communication and education contribute to an effective formulary system.
    Hinthorn D; Godwin H
    Hosp Formul; 1989 May; 24(5):281-4, 286-7. PubMed ID: 10292977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Achieving an effective committee through reorganization: the Ohio State University Hospital's experience.
    Lewis RP; Moore TD
    Hosp Formul; 1991 Feb; 26(2):120-30. PubMed ID: 10109143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing--2001.
    Pedersen CA; Schneider PJ; Santell JP
    Am J Health Syst Pharm; 2001 Dec; 58(23):2251-66. PubMed ID: 11763804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Managing conflicts of interest in pharmacy and therapeutics committees: A proposal for multicentre formulary development.
    Friesen P; Caplan AL; Miller JE
    J Clin Pharm Ther; 2020 Apr; 45(2):249-255. PubMed ID: 31657022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug formulary decision-making: Ethnographic study of 3 pharmacy and therapeutics committees.
    Schiff GD; Tripathi JB; Galanter W; Paek JL; Pontikes P; Fanikos J; Matta L; Lambert BL
    Am J Health Syst Pharm; 2019 Apr; 76(8):537-542. PubMed ID: 30915453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The P&T committee: Clinical Hospital Center, Zagreb, Yugoslavia.
    Vrhovac B; Francetic I
    Hosp Formul; 1984 Dec; 19(12):1158-9, 1162. PubMed ID: 10269439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. P & T Committee formulary requests: criteria for admission.
    Weintraub M; Guttmacher L
    Hosp Formul; 1984 Oct; 19(10):975-7, 980. PubMed ID: 10268315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of Hospital Formularies in Ontario: Challenges within a Local Health Integration Network.
    Burke N; Bowen JM; Troyan S; Jegathisawaran J; Gosse C; Tonkin M; Kagoma S; Goeree R; Holbrook A
    Can J Hosp Pharm; 2016; 69(3):187-93. PubMed ID: 27402997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guidelines on the operation of the pharmacy and therapeutics committee and formulary.
    Linkewich JA; Prevoznik SJ
    Hosp Pharm; 1979 Jan; 14(1):7-10, 13, 16-9 passim. PubMed ID: 10240149
    [No Abstract]   [Full Text] [Related]  

  • 38. P&T committee: an approach to formulary consideration of antimicrobial agents--introduction.
    Andriole VT; Ryan JL
    Hosp Formul; 1981 Jun; 16(6):619, 623. PubMed ID: 10251442
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug approval processes in Australian Paediatric Hospitals.
    Sinha YK; Craig JC; Barclay P; Taitz J; South M; Coulthard K; Pearson C; Erickson S; Brien JE
    Arch Dis Child; 2010 Sep; 95(9):739-44. PubMed ID: 20584852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving pharmacy and therapeutics committee operations.
    Cohen MR; Klapp D; Miller KB; Shaffer VL; Slotfeldt M; Miller DE
    Am J Hosp Pharm; 1984 Sep; 41(9):1767-77. PubMed ID: 6496511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.